Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues
Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues Company continues to report a significant impact of biosimilar competition on established brands Roche has reported its first quarter results for 2021, with its diagnostics business continuing to grow as the company’s pharmaceuticals division struggles to combat biosimilar competition. Overall, group sales were up by 3% at constant exchange rates (CER), with a 1% decline reported in Swiss francs as a result of the increasing value of the currency. The company’s pharma division, in particular, took a hit, ...
Source: pmlive.com